Alopecia Areata: all 469 studies

Page 1 of 5. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• UV-Trichoscopic Red Fluorescence in Alopecia AreataRecruitingNCT07803874
• A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia AreataRecruitingNCT07772492Phase 3
• A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataRecruitingNCT07762443Phase 1
• Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia AreataRecruitingNCT07749716Phase 2
• An Observational Study of Patients With Dermatologic DiseaseNot yet recruitingNCT07748169
• A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia AreataRecruitingNCT07733765Phase 3
• Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia AreataRecruitingNCT07733063
• The Role of Gut and Skin Microbiota in Alopecia AreataNot yet recruitingNCT07705217Not applicable
• New Topical Treatment in Patchy Alopecia AreataNot yet recruitingNCT07696585Not applicable
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia AreataRecruitingNCT07617597Phase 3
• Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose AdministrationRecruitingNCT07554222Phase 1
• A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)RecruitingNCT07533006Phase 2
• Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataEnrolling by invitationNCT07499713
• Topical Methotrexate vs Minoxidil for Localized Alopecia AreataNot yet recruitingNCT07459933Phase 4
• Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia AreataNot yet recruitingNCT07453238Phase 4
• Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)Not yet recruitingNCT07406204Phase 4
• Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyRecruitingNCT07381556Phase 4
• LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical PracticeNot yet recruitingNCT07336641
• A Study of LAD603 in Adults With Alopecia AreataRecruitingNCT07311564Phase 2
• PALLAS Laser for Skin DiseasesRecruitingNCT07250997Not applicable
• Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeRecruitingNCT07242638Phase 2
• A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.RecruitingNCT07205159Phase 1
• A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.RecruitingNCT07152119
• A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis SuppurativaRecruitingNCT07136467
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia AreataRecruitingNCT07133308Phase 3
• HCW9302 (Interleukin-2 Fusion Protein) for Alopecia AreataRecruitingNCT07049328Phase 1
• A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.RecruitingNCT07029828Phase 3
• Low Dose Oral Minoxdil in Androgenic AlopeciaNot yet recruitingNCT07018349Not applicable
• Efficacy of Dihydroartemisinin for Treating Female Androgenetic AlopeciaRecruitingNCT07012486Early Phase 1
• Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer PatientsRecruitingNCT06955702Not applicable
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataRecruitingNCT06873945Phase 3
• Autologous Adipose Cells TherapyRecruitingNCT06869252Phase 1/2
• Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 VolunteersRecruitingNCT06841458Not applicable
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia AreataRecruitingNCT06826196Phase 1/2
• Various Procedural Treatment Options for Androgenetic AlopeciaNot yet recruitingNCT06826001Phase 2
• The Effect of Coconut Oil on AlopeciaRecruitingNCT06818370Not applicable
• Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label StudyNot yet recruitingNCT06797310Phase 2
• The Lily Device TrialRecruitingNCT06786078Not applicable
• The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.Enrolling by invitationNCT06764329Phase 1/2
• Clinical Study of DA-007 for the Treatment of Chemotherapy Induced AlopeciaNot yet recruitingNCT06762548Phase 3
• Evaluation of Microbiota Transplant Therapy in Patients With Alopecia AreataRecruitingNCT06747611Phase 2
• To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic AlopeciaNot yet recruitingNCT06622824Phase 2/3
• Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy AdultsRecruitingNCT06603194Not applicable
• Benefits of a Cosmetic Anti-hair Loss in Males With Hair LossNot yet recruitingNCT06590779Not applicable
• Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE StudyRecruitingNCT06573593
• Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata PatientsNot yet recruitingNCT06562894Phase 2
• CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness RegistryRecruitingNCT06562270
• Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic AlopeciaNot yet recruitingNCT06558565Not applicable
• Clinical Study of DA-002 and DA-005 As a Treatment for Hair LossNot yet recruitingNCT06501924Phase 3
• Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic AlopeciaNot yet recruitingNCT06482541Phase 1
• The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss PatientsRecruitingNCT06440655Not applicable
• Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia AreataNot yet recruitingNCT06399783Phase 4
• Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair LossNot yet recruitingNCT06355856Phase 4
• Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia AreataRecruitingNCT06327581Not applicable
• Autologous Stromal Vascular Fraction in Treatment of Male Androgenic AlopeciaNot yet recruitingNCT06326359Not applicable
• A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoRecruitingNCT06319781
• Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental StudyEnrolling by invitationNCT06292533Not applicable
• Systemic Treatments for Alopecia Areata RegistryRecruitingNCT06283316
• Evaluation of Latanoprost Combined With Fractional Erbium- YAG LaserRecruitingNCT06239324Phase 1/2
• Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic AlopeciaRecruitingNCT06218498Not applicable
• Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic AlopeciaRecruitingNCT06218394Not applicable
• Excimer Light(308) Therapy for Resistant Alopecia AreataNot yet recruitingNCT06149936
• MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)RecruitingNCT06110377Phase 4
• Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia AreataRecruitingNCT06104839Phase 2
• Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia AreataNot yet recruitingNCT06088147Not applicable
• Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.Not yet recruitingNCT06087796Phase 1
• Study To Evaluate The Efficacy And Safety Profile of ECOHAIR in Chemo-induced Alopecia.RecruitingNCT06020586Not applicable
• A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia AreataRecruitingNCT06012240Phase 3
• Effectiveness of a Novel Dietary Ingredient on Hair Growth and Skin's AppearanceRecruitingNCT06010745Not applicable
• Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic AlopeciaRecruitingNCT05990400Phase 2/3
• Role of Bandage After FUE Hair TransplantationNot yet recruitingNCT05984862Not applicable
• Determinants of Chronic Inflammatory Skin Disease TrajectoriesRecruitingNCT05928169
• Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia AreataNot yet recruitingNCT05910138Not applicable
• Dupilumab in the Treatment of Pediatric Alopecia AreataRecruitingNCT05866562Phase 2
• Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata ParticipantsRecruitingNCT05865041Phase 2
• Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic AlopeciaNot yet recruitingNCT05864885Phase 1
• Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia AreataRecruitingNCT05861401Not applicable
• CorEvitas Alopecia Areata (AA) Safety and Effectiveness RegistryRecruitingNCT05745389
• Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
• Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic AlopeciaRecruitingNCT05611593Phase 1
• Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated FactorsRecruitingNCT05588310
• Regeneron AA Multicenter (Dupilumab)RecruitingNCT05551793Phase 2
• Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)AvailableNCT05522556
• Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataRecruitingNCT05398809Phase 2
• Sham LaserCap vs. LaserCap SD vs. LaserCap HD+RecruitingNCT05365360Not applicable
• Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced AlopeciaRecruitingNCT05177289Not applicable
• A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsEnrolling by invitationNCT05084417
• Fecal Transplant for Alopecia AreataNot yet recruitingNCT04833179Not applicable
• Expanded Access to UpadacitinibAvailableNCT04159597
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationNCT03976622
• Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia AreataRecruitingNCT03078686Not applicable
• Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial AlopeciasTerminatedNCT06357169Not applicableResults posted
• Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot StudyCompletedNCT06202560Not applicableResults posted
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata ParticipantsCompletedNCT06060977Phase 1/2Results posted
• Healthcare Disparities in Alopecia AreataCompletedNCT05727306Results posted
• A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of AgeCompletedNCT05650333Phase 1Results posted
• Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataCompletedNCT05589610Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia AreataTerminatedNCT05556265Phase 2Results posted
• Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia AreataCompletedNCT05368103Phase 2Results posted
• A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing AlopeciaCompletedNCT05332366Phase 2Results posted

← Alopecia Areata overview